1. Molecular analysis of genetic abnormalities in human gliomas;Bello, M.J.; Campos, J.M.; Kusak, M.E.; Vaquero, J.; Sarasa, J.L.; Pestana, A.;Cancer Genet Cytogenet,1994
2. TP53 gene mutations and 17p deletions in human astrocytomas;Chung, R.; Whaley, J.; Kely, N.; Anderson, K.; Louis, D.; Menon, A.;Genes Chromosorn Cancer,1991
3. p53 mutations are associated with 17p allied loss in grade II and grade III astrocytoma;Deimiling, A.; Eibl, R.H.; Ohgaki, H.; Louis, D.N.; Ammon, K.; Peterson, I.;Cancer Res,1992
4. Subsets of glioblastoma multiforme defined by molecular genetic analysis;Deimling, A.; Ammon, K.; Schoenfeld, D.; Wiestler, O.D.; Seizinger, B.R.; Louis, D.N.;Brain Pathology,1993
5. Amplified and rearranged epidermal growth factor receptor genes in human gliomas reveal deletions of sequences encoding portions of;Ekstrand, A.J.; Sugawa, N.; James, C.D.; Collins, V.P.,1992